⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10886322 | 1.00 | — | — | |
| SCHEMBL6818373 | 1.00 | — | — | |
| SCHEMBL13321126 | 1.00 | — | — | |
| SCHEMBL5523155 | 1.00 | — | — | |
| SCHEMBL12189864 | 1.00 | — | — | |
| SCHEMBL10886317 | 1.00 | — | — | |
| SCHEMBL13321206 | 1.00 | — | — | |
| SCHEMBL22456124 | 1.00 | — | — | |
| SCHEMBL22325470 | 1.00 | — | — | |
| SCHEMBL3637703 | 1.00 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114236008-B | Method for detecting content of D-ribose and 5-deoxy-D-ribofuranose in capecitabine intermediate | 山东铂源药业股份有限公司 | 2023-11-28 | — | — | CN | claimed |
| CN-111100172-B | Cytosidine derivative and method for preparing capecitabine medicine from same | 中国科学院昆明植物研究所 | 2023-03-17 | — | — | CN | claimed |
| CN-114236008-A | Method for detecting contents of D-ribose and 5-deoxy-D-ribofuranose in capecitabine intermediate | 山东铂源药业有限公司 | 2022-03-25 | — | — | CN | claimed |
| CN-114236008-B | Method for detecting content of D-ribose and 5-deoxy-D-ribofuranose in capecitabine intermediate | 山东铂源药业股份有限公司 | 2023-11-28 | — | — | CN | disclosed |
| CN-114236008-B | Method for detecting content of D-ribose and 5-deoxy-D-ribofuranose in capecitabine intermediate | 山东铂源药业股份有限公司 | 2023-11-28 | — | — | CN | disclosed |
| CN-114236008-B | Method for detecting content of D-ribose and 5-deoxy-D-ribofuranose in capecitabine intermediate | 山东铂源药业股份有限公司 | 2023-11-28 | — | — | CN | disclosed |
| CN-111072734-B | Uridine derivative and method for preparing doxifluridine medicament by using same | 中国科学院昆明植物研究所 | 2023-04-07 | — | — | CN | disclosed |
| CN-111100172-B | Cytosidine derivative and method for preparing capecitabine medicine from same | 中国科学院昆明植物研究所 | 2023-03-17 | — | — | CN | disclosed |
| CN-114236008-A | Method for detecting contents of D-ribose and 5-deoxy-D-ribofuranose in capecitabine intermediate | 山东铂源药业有限公司 | 2022-03-25 | — | — | CN | disclosed |
| CN-114236008-A | Method for detecting contents of D-ribose and 5-deoxy-D-ribofuranose in capecitabine intermediate | 山东铂源药业有限公司 | 2022-03-25 | — | — | CN | disclosed |
| CN-114236008-A | Method for detecting contents of D-ribose and 5-deoxy-D-ribofuranose in capecitabine intermediate | 山东铂源药业有限公司 | 2022-03-25 | — | — | CN | disclosed |
| WO-1996040707-A1 | WATER-SOLUBLE ADENOSINE KINASE INHIBITORS | GENSIA SICOR (US) | 1996-12-19 | — | — | WO | disclosed |
| EP-0682519-A1 | ADENOSINE KINASE INHIBITORS | GENSIA, INC. (US) | 1995-11-22 | — | — | EP | disclosed |
| WO-1994017803-A9 | ADENOSINE KINASE INHIBITORS | — | 1994-09-29 | — | — | WO | disclosed |
| WO-1994017803-A1 | ADENOSINE KINASE INHIBITORS | GENSIA, INC. (US) | 1994-08-18 | — | — | WO | disclosed |
| WO-1992012718-A1 | ADENOSINE KINASE INHIBITORS | GENSIA, INC. (US) | 1992-08-06 | — | — | WO | disclosed |
| EP-0496617-A1 | Adenosine kinase inhibitors | GENSIA, INC. (US) | 1992-07-29 | — | — | EP | disclosed |
| EP-0063481-B1 | WATER-SOLUBLE ANTITUMOR, ANTIVIRAL AND IMMUNOSUPPRESSANT COMPOUNDS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1984-10-17 | — | — | EP | disclosed |
| US-4464531-A | ANTITUMOR AGENT | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1984-08-07 | — | — | US | disclosed |
| EP-0063481-A1 | Water-soluble antitumor, antiviral and immunosuppressant compounds | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1982-10-27 | — | — | EP | disclosed |